MRNA

Marina Biotech, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 9/21/2017
Contact Info
  • 17870 Castleton Street
  • Suite 250
  • City of Industry, CA 91748

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0000737207
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1983
Employees 4 a/o Mar 31, 2017
Company Officers/Contacts
Joseph W. Ramelli CEO
Mihir Munsif COO
Amit Shah CFO
Erik Emerson Chief Commercial Officer
Larn Hwang Chief Scientific Officer
Company Directors
Vuong Trieu Executive Chairman
Donald A Williams Independent Director, Audit Committee Member, Compensation Committee Member
Service Providers
Accounting/Auditing Firm
Squar, Milner, Peterson, Miranda & Williamson, LLP
4100 Newport Place Drive
Newport Beach, CA, 92660
United States
 
Securities Counsel
Pryor Cashman LLP OTCQX Sponsor
7 Times Square
New York, NY, 10036-6569
United States
 
Investor Relations Firm
Kanan Corbin Schupak & Aronow, Inc.
880 Third Avenue
6th Floor
New York, NY, 10022
United States
 
Company History
  • Formerly= MDRNA,Inc. until 7-2010
  • Formerly=Nastech Pharmaceutical Co., Inc. until 6-2008
MRNA Security Details
Share Structure
Market Value1 $23,611,032 a/o Oct 20, 2017
Authorized Shares 180,000,000 a/o Sep 20, 2017
Outstanding Shares 9,837,930 a/o Sep 20, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.006
Shareholders
Shareholders of Record 277 a/o Sep 20, 2017
Short Selling Data
Short Interest 42,078 (10.21%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security